Mercer Global Advisors’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15.1M | Sell |
68,290
-933
| -1% | -$258K | 0.02% | 444 |
|
|
2026
Q1 | $20.4M | Buy |
69,223
+370
| +0.5% | +$110K | 0.03% | 311 |
|
|
2025
Q4 | $18.8M | Buy |
68,853
+4,842
| +8% | +$1.32M | 0.03% | 346 |
|
|
2025
Q3 | $17.3M | Buy |
64,011
+1,221
| +2% | +$332K | 0.03% | 347 |
|
|
2025
Q2 | $17.3M | Buy |
62,790
+3,901
| +7% | +$1.06M | 0.04% | 276 |
|
|
2025
Q1 | $15.6M | Buy |
58,889
+4,911
| +9% | +$1.21M | 0.04% | 273 |
|
|
2024
Q4 | $12.5M | Sell |
53,978
-3,801
| -7% | -$874K | 0.03% | 310 |
|
|
2024
Q3 | $13M | Buy |
57,779
+10,398
| +22% | +$2.15M | 0.03% | 272 |
|
|
2024
Q2 | $9.29M | Sell |
47,381
-2,702
| -5% | -$558K | 0.03% | 314 |
|
|
2024
Q1 | $10.8M | Sell |
50,083
-4,277
| -8% | -$898K | 0.03% | 297 |
|
|
2023
Q4 | $11.4M | Buy |
54,360
+2,076
| +4% | +$443K | 0.03% | 282 |
|
|
2023
Q3 | $10.5M | Sell |
52,284
-18,511
| -26% | -$3.68M | 0.04% | 265 |
|
|
2023
Q2 | $13.1M | Buy |
70,795
+41,624
| +143% | +$7.69M | 0.05% | 238 |
|
|
2023
Q1 | $5.59M | Buy |
29,171
+5,774
| +25% | +$1.04M | 0.03% | 401 |
|
|
2022
Q4 | $3.93M | Buy |
23,397
+4,469
| +24% | +$777K | 0.02% | 496 |
|
|
2022
Q3 | $3.35M | Sell |
18,928
-696
| -4% | -$138K | 0.02% | 490 |
|
|
2022
Q2 | $4.02M | Sell |
19,624
-484
| -2% | -$103K | 0.02% | 420 |
|
|
2022
Q1 | $4.78M | Buy |
20,108
+9,259
| +85% | +$2.17M | 0.03% | 395 |
|
|
2021
Q4 | $2.48M | Buy |
10,849
+3,315
| +44% | +$729K | 0.02% | 550 |
|
|
2021
Q3 | $1.46M | Buy |
7,534
+1,952
| +35% | +$395K | 0.01% | 731 |
|
|
2021
Q2 | $1.19M | Buy |
5,582
+1,187
| +27% | +$251K | 0.01% | 762 |
|
|
2021
Q1 | $897K | Buy |
4,395
+2,195
| +100% | +$432K | 0.01% | 826 |
|
|
2020
Q4 | $400K | Sell |
2,200
-701
| -24% | -$119K | 0.01% | 954 |
|
|
2020
Q3 | $485K | Buy |
2,901
+1,265
| +77% | +$213K | 0.01% | 787 |
|
|
2020
Q2 | $266K | Sell |
1,636
-8
| -0.5% | -$1.43K | ﹤0.01% | 890 |
|
|
2020
Q1 | $284K | Buy |
1,644
+6
| +0.4% | +$1.19K | 0.01% | 826 |
|
|
2019
Q4 | $329K | Buy |
1,638
+443
| +37% | +$90.9K | 0.01% | 879 |
|
|
2019
Q3 | $252K | Sell |
1,195
-431
| -27% | -$90.1K | 0.01% | 948 |
|
|
2019
Q2 | $316K | Sell |
1,626
-218
| -12% | -$40.2K | 0.01% | 852 |
|
|
2019
Q1 | $304K | Buy |
+1,844
| New | +$326K | 0.01% | 815 |
|
Other funds holding CME
Mercer Global Advisors's CME Position: Q2 2026 in Review
Mercer Global Advisors reduced its CME Group (CME) stake by 1.3% in Q2 2026, selling an estimated $258K and leaving 68,290 shares worth $15.1M. The position accounts for 0.02% of the portfolio, ranked #444.
Mercer Global Advisors first reported a position in CME in Q1 2019 and has held it in 30 quarters since. The position peaked at $20.4M in Q1 2026. 1,705 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Mercer Global Advisors held 68,290 shares of CME Group worth $15.1M as of Q2 2026.
- Mercer Global Advisors sold 933 CME Group shares in Q2 2026, an estimated $258K.
- CME Group made up 0.02% of Mercer Global Advisors's portfolio in Q2 2026, its #444 holding.
- Mercer Global Advisors first reported a position in CME Group in Q1 2019 and has held it in 30 quarters since.
- Mercer Global Advisors's CME Group position peaked at $20.4M in Q1 2026.
- 1,705 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.